Carisma Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CARM and buy or sell other stocks, ETFs, and their options commission-free!About CARM
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors.
CEOSteven Kelly, MBA
CEOSteven Kelly, MBA
Employees46
Employees46
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2016
Founded2016
Employees46
Employees46
CARM Key Statistics
Market cap1.89M
Market cap1.89M
Price-Earnings ratio0.22
Price-Earnings ratio0.22
Dividend yield—
Dividend yield—
Average volume390.81K
Average volume390.81K
High today$0.0499
High today$0.0499
Low today$0.0417
Low today$0.0417
Open price$0.0485
Open price$0.0485
Volume127.08K
Volume127.08K
52 Week high$1.27
52 Week high$1.27
52 Week low$0.0261
52 Week low$0.0261
Stock Snapshot
The current Carisma Therapeutics(CARM) stock price is $0.04, with a market capitalization of 1.89M. The stock trades at a price-to-earnings (P/E) ratio of 0.22.
On 2025-11-25, Carisma Therapeutics(CARM) stock traded between a low of $0.04 and a high of $0.05. Shares are currently priced at $0.04, which is +3.1% above the low and -13.8% below the high.
Carisma Therapeutics(CARM) shares are trading with a volume of 127.08K, against a daily average of 390.81K.
During the past year, Carisma Therapeutics(CARM) stock moved between $0.03 at its lowest and $1.27 at its peak.
During the past year, Carisma Therapeutics(CARM) stock moved between $0.03 at its lowest and $1.27 at its peak.
People also own
Based on the portfolios of people who own CARM. This list is generated using Robinhood data, and it’s not a recommendation.